The role of GABAb receptor mechanisms in cough: a double-blind, randomised controlled trial of Lesogaberan in chronic cough patients with positive and negative symptom association probabilities
Phase of Trial: Phase II
Latest Information Update: 05 Sep 2017
At a glance
- Drugs Lesogaberan (Primary)
- Indications Cough
- Focus Therapeutic Use
- Acronyms GARMIN-II
- 04 Apr 2017 Planned End Date changed from 16 Apr 2016 to 1 Sep 2017.
- 04 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 11 Dec 2015 Accrual to date is 20% according to United Kingdom Clinical Research Network record.